- Email: [email protected]
Erratum to “Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin” [Pharm. Res. 49 (1) 73–77]
Pharmacological Research 49 (2004) 299
Erratum
Erratum to “Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin” [Pharm. Res. 49 (1) 73–77]夽 Lucia Calò, Francesca Fornelli, Rossella Ramires, Saverio Nenna, Alfredo Tursi, Maria Filomena Caiaffa, Luigi Macchia∗
In the above paper, the first sentence in paragraph 2.2 appears incorrectly. The corrected version appears below: Beauvericin cytotoxicity to U-937 and HL-60 cells (both undifferentiated and eosinophilic-differentiated cultures)
夽 doi
of original article: 10.1016/j.phrs.2003.07.002. author. E-mail address: [email protected] (L. Macchia).
∗ Corresponding
1043-6618/$ – see front matter © 2003 Elsevier Ltd. All rights reserved. doi:10.1016/j.phrs.2003.11.008
was assayed primarily by exposing micro cultures (usually 300 l, in 96-well plates; Falcon, Bedford, MA, USA) in early stationary phase to beauvericin (Sigma), at concentrations ranging from 100 nM to 300 M.
Erratum
Erratum to “Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin” [Pharm. Res. 49 (1) 73–77]夽 Lucia Calò, Francesca Fornelli, Rossella Ramires, Saverio Nenna, Alfredo Tursi, Maria Filomena Caiaffa, Luigi Macchia∗
In the above paper, the first sentence in paragraph 2.2 appears incorrectly. The corrected version appears below: Beauvericin cytotoxicity to U-937 and HL-60 cells (both undifferentiated and eosinophilic-differentiated cultures)
夽 doi
of original article: 10.1016/j.phrs.2003.07.002. author. E-mail address: [email protected] (L. Macchia).
∗ Corresponding
1043-6618/$ – see front matter © 2003 Elsevier Ltd. All rights reserved. doi:10.1016/j.phrs.2003.11.008
was assayed primarily by exposing micro cultures (usually 300 l, in 96-well plates; Falcon, Bedford, MA, USA) in early stationary phase to beauvericin (Sigma), at concentrations ranging from 100 nM to 300 M.